Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, October 28 at 2:00 PM ET

Register Free →

This Solicitation opportunity from Department Of Defense was posted on May 1, 2020. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

Automated Immunology Testing Platform - CPRR

Closed
W9114F-20-Q-0051Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

General Info

NAICS

339112 - Surgical and Medical Instrument Manufacturing

Place of Performance

AE

Set-Aside

NONE

Documents

3

Conformed+W9114F20Q0051-0001.pdf

PDF

W9114F20Q00510001Amended.pdf

PDF

W9114F-20-Q-0051.pdf

PDF

AI Contract Breakdown

Uniform Contract Format

Contract not broken down yet

CLEATUS splits the solicitation into Uniform Contract Format (UCF) sections: scope, pricing, deliverables, and evaluation criteria.

Timeline

1 update
PhaseClosed
Posted

Solicitation

Notice updated

The notice description changed.

Response Deadline

Deadline has passed

Submission Closed

Find active opportunities like this

Start your free trial to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

Show more
AgencyDepartment Of Defense → W40M Mrco Europe
Contacts1 person available
OfficeAPO, AE, 09180-0402, USA
Office AddressAPO, AE, 09180-0402, USA
Contacts
Donna Kabatek

Full Description

Show more
The Vendor shall provide all labor, materials and transportation necessary to provide one (1) new, fully-automated immunoassay testing platform on a cost-per-reportable test basis with the purchase of reagents. The system must be a fully automated, random access immunoassay system using direct or indirect chemiluminescence or fluorescence. Assay method must be able to perform FDA-approved tests capable of producing clinical results in accordance with the College of American Pathologist (CAP) and CLIP/CLIA/CLSI guidelines. Items included are the analyzer, printer, training, supplies, reagents, controls, unscheduled maintenance, and preventive maintenance for the equipment. The system will be able to test for the following analytes as listed in the Salient Characteristics: CMV IgG / IgM, HSV 1/2 IgG,Mumps IgG, Rubeola IgG, Varicella-zoster virus IgG, Lyme IgG / IgM. The Offeror is responsible for customer service and support 24 hours/7 days a week to ensure continued ability to conduct assays. This solicitation is amended to reflect new quantities on each CLIN, changing the quantity from 106,800 to 20,000.

More opportunities from Department Of Defense → W40M Mrco Europe

Same awarding agency

NAICS: 325413
Federal
Blood Chemistry Testing - Cost Per Reportable Result
Solicitation # W9114F-26-Q-A009
The Medical Readiness Contracting Office-Europe is soliciting a Fixed-Price Indefinite Delivery/Indefinite Quantity contract for one automated chemistry analyzer and associated consumables to support the laboratory mission at the U.S. Army Health Clinic in Vicenza, Italy. Under a Cost Per Reportable Result pricing structure, the successful offeror will provide all new equipment, reagents, consumables, controls, and necessary maintenance. The contract includes a two-month phase-in period from January 2, 2026, to February 28, 2026, followed by an ordering period from March 1, 2026, through December 31, 2030. The estimated annual clinical chemistry workload is 42,595 tests. Technical requirements specify that the analyzer must be FDA-approved, capable of measuring analytes from a 300-microliter sample, and equipped with an uninterruptible power supply providing seven minutes of power. The system must have a current Authorization to Operate for interfacing with the Laboratory Information System and comply with the Risk Management Framework for DOD IT. The contractor is responsible for providing initial on-site operator training in English and ensuring all reagents are delivered at the proper storage temperature. Award will be based on the Lowest Price Technically Acceptable evaluation process under Simplified Acquisition Procedures, with the solicitation open for full competition under NAICS code 325413.
In-Vitro Diagnostic Substance Manufacturing

POSTED

12 months ago

DEADLINE

N/A
View Details

Find Active Opportunities Like This

Get AI-powered intelligence on the opportunities still open

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS